Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POOMA outpatient vs inpatient management in pediatric acute osteomyelitis
2019-003522-25Phase 4Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amoxicillin + clavulanate in Acute osteomyelitis (AOM) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Complete recovery without relapse at 6 months. Started Dec 2019; status: active.
02
Drugs
amoxicillin + clavulanate
03
Conditions
Acute osteomyelitis (AOM)
Beyond the preview
Go deeper on 2019-003522-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003522-25.